XTL Biopharmaceutica (Israel) Technical Analysis Overview

    XTLB -- Israel Stock  

    ILS 10.90  0.20  1.87%

    XTL Biopharmaceuticals Ltd maintains Risk Adjusted Performance of 0.3108 and Mean Deviation of 5.07. In relation to Fundamental Indicators, Macroaxis technical analysis interface lets you check available technical drivers of XTL Biopharmaceuticals Ltd as well as the relationship between them. Specifically you can use this information to find out if the organization will indeed mirror its model of past data patterns or the prices will eventually revert. We found nineteen technical drivers for XTL Biopharmaceuticals which can be compared to its rivals. Please check out XTL Biopharmaceuticals Information Ratio, Treynor Ratio, Value At Risk, as well as the relationship between Jensen Alpha and Maximum Drawdown to decide if XTL Biopharmaceuticals is priced some-what accurately providing market reflects its latest price of 10.9 per share.
    Horizon     30 Days    Login   to change

    XTL Biopharmaceuticals Technical Analysis

    Indicator
    Time Period
      Portfolio Suggestion  Portfolio Suggestion  
      
    Execute Indicator
     
    We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

    XTL Biopharmaceuticals Trend Analysis

    Use this graph to draw trend lines for XTL Biopharmaceuticals Ltd. You can use it to identify possible trend reversals for XTL Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual XTL Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

    XTL Biopharmaceutica Best Fit Change Line

    The following chart estimates an ordinary least squares regression model for XTL Biopharmaceuticals Ltd applied against its price change over selected period. The best fit line has a slop of 0.20 % which means XTL Biopharmaceuticals Ltd will continue generating value for investors. It has 34 observation points and a regression sum of squares at 32.16, which is the sum of squared deviations for the predicted XTL Biopharmaceutica price change compared to its average price change.

    Did you try this?

    Run Portfolio Anywhere Now

       

    Portfolio Anywhere

    Track or share privately all of your investments from the convenience of any device
    All  Next Launch Portfolio Anywhere

    XTL Biopharmaceutica Market Strength

    XTL Biopharmaceutica October 21, 2018 Daily Price Condition

    See also Your Current Watchlist. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.
    Search macroaxis.com